These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12219622)

  • 1. [Essential basics in therapy of heart failure. Without diuretics the prognosis is poor].
    Bischoff A
    MMW Fortschr Med; 2002 Jul; 144(29-30):6-8. PubMed ID: 12219622
    [No Abstract]   [Full Text] [Related]  

  • 2. [Why are results of studies with digitalis so poor? "It depends on potassium!"].
    Hien M
    MMW Fortschr Med; 2003 Oct; 145(43):21. PubMed ID: 14652934
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical pharmacology of diuretic drugs.
    Brest AN
    Cardiovasc Clin; 1984; 14(3):31-8. PubMed ID: 6722857
    [No Abstract]   [Full Text] [Related]  

  • 4. [The treatment of chronic cardiac decompensation].
    van Zanten RA; Laird-Meeter K
    Ned Tijdschr Geneeskd; 1987 Apr; 131(15):615-8. PubMed ID: 3574530
    [No Abstract]   [Full Text] [Related]  

  • 5. [Future aspects of therapy with diuretics].
    Düsing R
    Internist (Berl); 1992 Aug; 33 Suppl 1():S53-6. PubMed ID: 1428699
    [No Abstract]   [Full Text] [Related]  

  • 6. [Optimization of diuretic therapy in heart failure].
    Knauf H; Hasenfuss G; Just HJ
    Verh Dtsch Ges Inn Med; 1985; 91():155-67. PubMed ID: 4090614
    [No Abstract]   [Full Text] [Related]  

  • 7. [Challenge for the general practitioner. Sufficient therapy for heart failure].
    Füessl HS
    MMW Fortschr Med; 2000 Nov; 142(46):4-8. PubMed ID: 11132311
    [No Abstract]   [Full Text] [Related]  

  • 8. Beyond diuretics: management of volume overload in acute heart failure syndromes.
    Hill JA; Yancy CW; Abraham WT
    Am J Med; 2006 Dec; 119(12 Suppl 1):S37-44. PubMed ID: 17113399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of standard heart failure therapy and concomitant treatment with intravenous furosemide or inotropes (dobutamine, dopamine, and/or milrinone) on renal function and mortality in patients treated with nesiritide.
    Kurien S; Warfield KT; Wood CM; Miller WL
    Am J Cardiol; 2006 Dec; 98(12):1627-30. PubMed ID: 17145223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of intravenous diuretics alone versus diuretics plus parenteral vasoactive therapies in hospitalized patients with acutely decompensated heart failure: a propensity score and instrumental variable analysis using the Acutely Decompensated Heart Failure National Registry (ADHERE) database.
    Costanzo MR; Johannes RS; Pine M; Gupta V; Saltzberg M; Hay J; Yancy CW; Fonarow GC
    Am Heart J; 2007 Aug; 154(2):267-77. PubMed ID: 17643575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diuretics. Range of effect, indications and therapeutic results in heart diseases].
    Zidek W; Rahn KH
    Internist (Berl); 1992 Oct; 33(10):645-9. PubMed ID: 1428683
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mefrusid, a new diuretic. A clinical comparison with chlorthalidone with special reference to the water-electrolyte balance].
    Gisholt K; Berg KJ
    Tidsskr Nor Laegeforen; 1970 Jul; 90(13):1395-9. PubMed ID: 5453187
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertension and heart failure. Are there approaches for differential therapy?].
    Böhm M
    MMW Fortschr Med; 2000 Feb; 142(7):31-3. PubMed ID: 10832331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Heart failure. Can vasopressin antagonists improve the prognosis?].
    MMW Fortschr Med; 2003 Nov; 145(48):10. PubMed ID: 14724989
    [No Abstract]   [Full Text] [Related]  

  • 15. Practical applications of intravenous diuretic therapy in decompensated heart failure.
    Cleland JG; Coletta A; Witte K
    Am J Med; 2006 Dec; 119(12 Suppl 1):S26-36. PubMed ID: 17113397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of levosimendan added to dobutamine in patients with decompensated advanced heart failure refractory to dobutamine alone.
    Nanas JN; Papazoglou PP; Terrovitis JV; Kanakakis J; Dalianis A; Tsolakis E; Tsagalou EP; Agrios N; Christodoulou K; Anastasiou-Nana MI
    Am J Cardiol; 2004 Nov; 94(10):1329-32. PubMed ID: 15541261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A must in symptomatic heart failure. Added beta blocker improves prognosis].
    MMW Fortschr Med; 2001 Feb; 143(5):50-1. PubMed ID: 11234521
    [No Abstract]   [Full Text] [Related]  

  • 19. [Diuretics in the treatment of cardiac failure].
    Tourniaire A; Blum J; Gallet M; Lestaevel M
    Lyon Med; 1970 Mar; 223(13):707-16. PubMed ID: 5446468
    [No Abstract]   [Full Text] [Related]  

  • 20. [Time organization of blood coagulation in patients with rheumatic heart disease involving circulation insufficiency].
    Zaslavskaia RM; Logvinenko SI; Teiblium MM; Khalberg F
    Klin Med (Mosk); 1996; 74(8):25-9. PubMed ID: 9036201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.